# TIVDAK
> **BLA761208** · Biologics License Application · Sponsor: SEAGEN · Approved 2021-09-20
## Drug
- **FDA Application Number:** BLA761208
- **Application type:** Biologics License Application
- **Brand name:** TIVDAK
- **Generic name:** TISOTUMAB VEDOTIN
- **Active ingredients:** TISOTUMAB VEDOTIN-TFTV
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SEAGEN
- **Manufacturer:** SEAGEN INC.
- **First approval:** 2021-09-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761208)
---
*MORVS · CC0 1.0*